le mardi 04 juin 2019

Séminaire ComPaRe - Schizophrénie

Le Professeur Marie-Odile Krebs répond aux questions des comparnautes à propos de la schizophrénie. Marie-Odile Krebs est psychiatre et exerce à l'hôpital Sainte-Anne (Paris)....

le vendredi 24 mai 2019

Qu'est ce que l'anorexie mentale ?

Le Professeur Philip Gorwood répond aux questions des comparnautes à propos de l'anorexie. Le Professeur Gorwood est psychiatre à l'hôpital Sainte-Anne (Paris). ComPaRe : Communauté de Patients pour la Recherche...

vendredi 19 juillet 2019

The Michael J. Fox Foundation : Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy

The Michael J. Fox Foundation will award one- to three-year grants to develop imaging markers for use in disease-modifying clinical trials
Applications must focus on developing robust and precise imaging markers.

• Priority targets for this program are alpha-synuclein and neuroinflammation, but applications may focus on other promising therapeutic targets.
• Imaging modalities can include PET, SPECT and MRI.
• Projects should aim to develop novel imaging biomarkers as opposed to prospectively collecting data using existing technologies. Prospective data collection is appropriate only if a novel imaging technique or tracer is being tested. Novel data analysis techniques may be proposed but should utilize existing data sets.
• Examples of projects that are appropriate for this program include development of novel PET or SPECT tracers, early validation of new tracers, and development and validation of novel MRI techniques.

Deadlines :
Pre-Proposals Due: April 19, 2019, 5 p.m. ET
Full Proposal Invitations: Week of June 10, 2019
Full Proposals Due (by invite only): July 19, 2019, 5 p.m. ET
Anticipated Award Announcement: September 2019
Anticipated Funding: October 2019

More information : https://www.michaeljfox.org/research/grant-detail.php?id=41

lundi 15 juillet 2019

La Commission européenne recrute un panel d'experts

La Commission européenne recrute des experts dans le domaine de la santé. Ils rejoindront le panel multisectoriel et indépendant qui conseille la Commission sur les moyens efficaces d'investir dans la santé.

Date limite : 15 juillet 2019

+ d'infos : http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2847

mercredi 01 janvier 2020

European Brain Research Area consortium (EBRA): Call for clusters

The EBRA consortium is launching a Call for Clusters to promote co-operation and exchange between brain research projects and networks, and thus enable or enhance international collaboration and the emergence of development of clusters in all areas of brain research.

A cluster is understood as an association of research projects that can be directed towards basic research, clinical research and/or methodological approaches under a common topic, and disease and/or thematic area.

The individual members of a cluster application should be complementary.

The cluster formation should lead to a step-wise change in the landscape of that research area and should demonstrate a clear added-value in the collaboration/cooperation over individual projects including, but not limited to, sharing of resources (models, databases, diagnostics etc.), harmonisation of data, sharing of specific know-how and/or innovative technologies, etc.

The EBRA call for cluster is an open call until 1 January 2021.

Deadlines

1 June 2019
1 January 2020
1 June 2020
1 January 2021

More information: https://www.ebra.eu/Call4Clusters/